Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification
Jonathan Larkin(Target (United States)), Christopher Matheny(GlaxoSmithKline (United Kingdom)), Tessa Lohr(Target (United States)), Louis Elefante(Target (United States)), Rachel E. Miller(Northwestern University), Yu Xue(Hefei National Center for Physical Sciences at Nanoscale), Curtis C. Maier(GlaxoSmithKline (United Kingdom)), Anne‐Marie Malfait(Rush University Medical Center), Caroline A. Genell(GlaxoSmithKline (United Kingdom)), Jean Shearin(GlaxoSmithKline (United States)), Phuong B. Tran(Center for Rheumatology), F. Liu(GlaxoSmithKline (United States)), Jing Su(GlaxoSmithKline (United States)), Rosalie Matico(GlaxoSmithKline (United States))
Cited by 118
Related Papers
IBS: an illustrator for the presentation and visualization of biological sequences
|Bioinformatics|2015|1.1k
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
|Proceedings of the National Academy of Sciences|2000|662
GPS 2.0, a Tool to Predict Kinase-specific Phosphorylation Sites in Hierarchy
|Molecular & Cellular Proteomics|2008|630
GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs
|Nucleic Acids Research|2014|541
Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS‐4 and ADAMTS‐5
|Arthritis & Rheumatism|2007|403